Qureight

qureight.com | TechBio, Healthtech, AI

Year2024

RoundSeries A

Amount$8.5M

Story

Design

Overall

Storyline

11 slides

Title

1 slide

Data curation to accelerate drug development.

Mission-Vision

1 slide

Qureight accelerates clinical trial development through data curation and AI to bring better therapies to patients with high unmet needs.

Traction

1 slide

Our customers, including AstraZeneca and Vicore, use us to support billion dollar decisions, pushing boundaries in respiratory disease research.

Problem

1 slide

Clinical trial data analysis is broken, risking failed drugs and huge financial losses, as evidenced by Roche's failed $1.4Bn investment and $200M trial loss.

Solution

2 slides

Qureight offers a single platform to streamline clinical trial data, enabling faster, more accurate drug development decisions by consolidating and analyzing data with AI.

Product

1 slide

Our key products include AI image analysis, virtual trial arms, and Central Read System, all designed to enhance clinical trial efficiency and decision-making.

Competition

1 slide

The competitive landscape is fragmented, with CROs, Pharma, and Med tech AI struggling with siloed data, lack of real-world datasets, and technological limitations.

Market Opportunity

1 slide

The global lung and heart clinical trials market is projected to grow significantly, with Qureight positioned to capitalize on over 3200 trials per year.